Download MarketsandMarkets Presents

MarketsandMarkets
Presents
Single-use Bioreactors Market worth 1,085.7 Million USD by 2021
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
The report "Single-use Bioreactor Market by Product (Stem cells, Interferons),
Cell (Yeast, Plant cells), Technology (Bubble column bioreactors), Application
(R&D, Bioproduction), End User (R&D department, Biopharmaceutical
manufacturers) - Global Forecast to 2021", The single-use bioreactors market is
projected to reach USD 1,085.7 Million by 2021 from USD 408.4 Million in 2016,
growing at a CAGR of 21.6% during the forecast period of 2016 to 2021.
Browse 115 market data Tables and 55 Figures spread through 148 Pages and
in-depth TOC on "Single-use Bioreactor Market by Product (Stem cells,
Interferons), Cell (Yeast, Plant cells), Technology (Bubble column bioreactors),
Application (R&D, Bioproduction), End User (R&D department,
Biopharmaceutical manufacturers) - Global Forecast to 2021“
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
Early buyers will receive 10% customization on this report.
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
• Improved returns on investment for small companies and
startups, and reduced complexity of automation are the major
factors driving the adoption of single-use bioreactors. On the
other hand, regulatory concerns related to SUBs and issues
regarding leachables and extractables are the major factors
restraining the growth of this market.
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
• The single-use bioreactors market is segmented on the basis
of product type, cell type, technology, application, end user,
and region. Based on product type, the market is segmented
into monoclonal antibodies, vaccines, gene-modified cells,
recombinant proteins, stem cells, and other products (growth
factors, interferons, and antisense DNA & RNA). The
monoclonal antibodies segment is expected to dominate this
market primarily due to the rising demand for monoclonal
antibodies in medical treatments owing to their high
therapeutic efficiency.
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
• On the basis of cell type, the single-use bioreactors market is
categorized into mammalian cells, bacteria, yeast, and other
cells (insect cells and plant cells). In 2016, the mammalian
cells segment is expected to account for the largest share of
the single-use bioreactors market owing to the increasing
application of these cells in biologics manufacturing as a
result of the highly mechanized metabolic machinery
required for complex biomolecules.
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
• Based on technology, the market is segmented into waveinduced motion SUBs, stirred SUBs, single-use bubble column
bioreactors, and other technologies. The wave-induced
motion SUBs segment is expected to account for the largest
market share in 2016. Growth in this segment can be
attributed to the advantages of wave-induced motion SUBs,
such as high flexibility and shorter lead times.
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
• The application segments in the single-use bioreactors
market include bioproduction processes, process
development, and research & development. The
bioproduction processes segment is expected to account for
the largest market share in 2016. Considering advantages
such as low investments and easy implementation, single-use
bioreactors are increasingly being adopted in bioproduction
processes. This is the major factor responsible for the large
share of this application segment.
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
• The major players operating in the single-use bioreactors
market include Sartorius Stedim Biotech SA (France), Merck
Millipore (Germany), GE Healthcare (U.K.), Danaher
Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.).
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
Contact Us
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]
http://www.linkedin.com/company/marketsandmarkets
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html
About MarketsandMarkets
MarketsandMarkets is the global market research and consulting company based in the
U.S. We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.
M&M’s flagship competitive intelligence and market research platform, "RT" connects
over 200,000 markets and entire value chains for deeper understanding of the unmet
insights along with market sizing and forecasts of niche markets. The new included
chapters on Methodology and Benchmarking presented with high quality analytical
infographics in our reports gives complete visibility of how the numbers have been
arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactormarket-49113750.html